Biotech Values

[DewDiligence]

AZN—Too bad no one has tested Imfinzi* concurrently with chemo/radiation in Stage-III NSCLC. That might work even better than waiting to start Imfinzi, although the concurrent toxicity could be a problem for some patients.

*Or another PD-(L)1 inhibitor.